Liver enzymes and histology in obese patients with obstructive sleep apnea

Journal of Clinical Gastroenterology

Volumn 41, Issue 10, 2007, Pages 918-921

  Kallwitz, Eric R ^a,c   Herdegen, James ^a   Madura, James ^b   Jakate, Shriram ^b   Cotler, Scott J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c Section of Digestive Diseases and Nutrition (MC 716)   (United States)

Author keywords

Liver histology; Nonalcoholic fatty liver disease; Obesity; Sleep apnea

Indexed keywords

ALANINE AMINOTRANSFERASE; LIVER ENZYME;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; ENZYME BLOOD LEVEL; FATTY LIVER; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER DISEASE; OBESITY; PREVALENCE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; STATISTICAL SIGNIFICANCE; STOMACH BYPASS;

ADULT; ALANINE TRANSAMINASE; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; SLEEP APNEA, OBSTRUCTIVE;

EID: 37349033894     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225692.62121.55     Document Type: Article

References (18)

1. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
2. Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States. JAMA. 1999;282:1519-1522.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.
4. Tanne F, Gagnadoux F, Chazouilleres O, et al. Chronic liver injury during obstructive sleep apnea. Hepatology. 2005;41:1290-1296.
5. Chin K, Nakamura T, Takahashi K, et al. Effects of obstructive sleep apnea on serum aminotransferase levels in obese patients. Am J Med. 2003;114:370-376.
6. Brunt E. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3-20.
7. Wanless I, Shiota K. The pathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:99-106.
8. Oliveira C, Faintuch J, Rascovski A, et al. Lipid peroxidation in bariatric candidates with nonalcoholic fatty liver disease (NAFLD) - preliminary findings. Obes Surg. 2005;15:502-505.
9. IP M, Lam B, Ng M, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670-676.
10. Punjabi N, Sorkin J, Katzel L, et al. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677-682.
11. Vgontzas A, Papanicolaou D, Bixler E, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:1151-1158.
12. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: UCLA Brain Information Service/Brain Research Institute; 1968.
13. Ross SD, Sheinhait MA, Harrison KJ, et al. Systemic review and meta-analysis of the literature regarding the diagnosis of sleep apnea. Sleep. 2000;23:1-14.
14. Diagnosis and Treatment of Obstructive Sleep Apnea. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2004 May 53 p.
15. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165:447-452.
16. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long term follow up study. Eur Heart J. 2004;25:728-734.
17. Beymer C, Kowdley K, Larson A, et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch Surg. 2003;138:1240-1244.
18. Lima M, Mourao S, Diniz M, et al. Hepatic histopathology of patients with morbid obesity submitted to gastric bypass. Obes Surg. 2005;15:661-669.